Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Bristol-Myers Close to Closing ZymoGenetics Deal

By Pharmaceutical Processing | October 8, 2010

NEW YORK (AP) — Bristol-Myers Squibb Co. said Friday it will soon complete
the buyout of drugmaker ZymoGenetics Inc. now that shareholders of that company
have tendered about 95 percent of their stock in favor of the deal.

On Sept. 10, Bristol-Myers said it would buy ZymoGenetics for $735 million
excluding cash on hand. That equaled a per-share price of $9.75 per share, which
represented a 77 percent premium to Zymogenetics’ closing price of $5.51 prior
to the initial announcement.

Seattle’s ZymoGenetics makes Recothrom, a drug used to reduce bleeding during
surgeries.

The tender offer closed on Thursday with ZymoGenetics shareholders tendering
just over 82.6 million shares of the company’s stock, representing about 95
percent of shares outstanding.

Bristol-Myers intends to complete the buyout ZymoGenetics through a
“short-form merger,” that is, without a vote or meeting of the remaining
ZymoGenetics shareholders. Each of the remaining shares of ZymoGenetics common
stock will be converted into the right to receive $9.75 per share in cash.

Morgan Stanley & Co. Inc. is serving as the financial adviser to
Bristol-Myers and as the deal manager for the tender offer.

Related Articles Read More >

This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
PHARMAP 2025: Pharma leaders converge in Berlin for fifth anniversary summit
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE